Back to Search Start Over

[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China].

Authors :
Zhang W
Chen Z
Li XM
Gao J
Zhao Y
Source :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2023 Sep 01; Vol. 62 (9), pp. 1059-1067.
Publication Year :
2023

Abstract

Sjögren's syndrome (SS) is a chronic systemic autoimmune disease characterized by lymphocyte proliferation and progressive exocrine gland damage. In addition to the impairment of salivary and lacrimal gland function, SS can present with multi-system and multi-organ involvement, accompanied by autoantibodies in serum and hyperimmunoglobulinemia. SS can be divided into primary and secondary forms based on the absence or presence, respectively, of concurrent connective tissue diseases such as systemic lupus erythematosus and rheumatoid arthritis. Based on evidence and guidelines from China and other countries, the Chinese Rheumatology Association drafted standardized criteria for the diagnosis and treatment of primary SS. The objectives were to standardize the detection and interpretation of key indicators for the diagnosis of SS, including serum anti-SSA antibody and labial gland pathology, suggest the use of the widely accepted European League Against Rheumatism (EULAR)-SS disease activity index for the evaluation of the disease, and standardize the rational management of SS patients with topical and systemic therapies.

Details

Language :
Chinese
ISSN :
0578-1426
Volume :
62
Issue :
9
Database :
MEDLINE
Journal :
Zhonghua nei ke za zhi
Publication Type :
Academic Journal
Accession number :
37650179
Full Text :
https://doi.org/10.3760/cma.j.cn112138-20221027-00797